SynthesisOrphanet journal of rare diseases2018

The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis.

Nannan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.